Immune Features of Ovarian Tumors with a Good Response to Neo-Adjuvant Chemotherapy in Combination with an Anti-Pd-l1 Alone or with an Anti-Ctla4: Data from the Randomized IneOV Trial (a GINECO Study)
Journal of clinical oncology(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要